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ABSTRACT 
THE INFLUENCE OF CHROMIUM SUPPLEMENTATION ON THE INSULIN 
PATHWAY, CARCASS TRAITS, AND MEAT QUALITY OF FEEDLOT STEERS 
HEATHER RENAE RODE 
2017 
Chromium supplementation (Cr) can increase efficiency of growth in livestock by 
amplifying insulin signaling. Previous research showed Cr increases nutrient utilization 
and changes in muscle growth and fat deposition. Therefore, the objective of this research 
was to determine how Cr affects carcass traits, meat quality, and the insulin pathway in 
feedlot steers. Calf-fed steers were allotted to 0 ppb (CON) or 400 ppb Cr propionate 
(Cr400) for 210d in experiment 1. Two longissimus muscle (LM) biopsies were collected 
to examine protein abundance and gene expression after adaptation to a terminal implant 
and after adaption to ractopamine hydrochloride (RAC). A follow up study, Experiment 
2, was conducted with yearling steers supplemented 0 ppb (CON) or 300 ppb Cr 
propionate (Cr300) for 138d. Cattle were transported to a commercial packing plant for 
slaughter. Carcass data was collected as well as strip loins for shear force and proximate 
analysis in both experiments. Carcass composition was estimated using 9-10-11 rib 
dissections with subsequent proximate analysis. Biopsies were used to analyze 
peroxisome proliferator activated receptor γ (PPARγ), protein kinase B (Akt), phospho-
Akt, and ribosomal protein S6 kinase 1 (p70S6K) abundance and glucose transporters 
(GLUT) 4 and 1 gene expression. Experiment 1 showed an increase in dressing 
percentage (DP), KPH, and shear force, but a decrease in marbling for Cr400 steers. Final 
BW, HCW, 12th rib backfat (BF), LMA, yield grade (YG), or carcass composition were 
 
 
xiv 
not different between treatments. Also, there was no difference in abundance of Akt, 
phospho-Akt, or p70S6K after the terminal implant, but PPARγ tended to be higher for 
CON. No differences were observed in protein abundance after RAC supplementation. 
Expression of GLUT4 and GLUT1 was not different after either biopsy. In experiment 2, 
there was no difference in final BW, HCW, BF, LMA, YG, DP, marbling score, chemical 
fat, or shear force. However, percent KPH tended to increase for CON. Variation 
between studies may be attributed to differences in duration of Cr and the animal model 
used. In conclusion, earlier and longer Cr supplementation can positively increase DP, 
but may have negative impacts on beef quality with calf-fed steers.  
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CHAPTER 1 
LITERATURE REVIEW 
Introduction  
 Since 1975, the U.S. cattle herd has shrunk from 140 million head to 92 million 
head as recently reported by the United States Department of Agriculture (USDA) 
(Meyer, 1997; Koontz, 2010; USDA, 2016). The decline in the cattle herd is partially 
attributed to a decrease in red meat consumption, because consumer demand for beef is 
half of what it was in 1980 (Andersen et al., 2002; Koontz, 2010). More recently in 2013, 
a significant portion of the decline was attributed to drought that caused ranches to 
liquidate cattle number (USDA, 2016). Also, cattle producers now have to compete with 
ethanol production for corn, which has caused increases in feed costs (Lawrence et al., 
2008). All of these factors coupled with the opportunities to sell land to capture equity, 
lack of interest from the younger generation, and increasing input costs have all played a 
role in ranchers exiting the industry never to reinvest (Field, 2010). This has left the 
remaining ranchers to produce more beef with fewer cattle (Field, 2010; Koontz, 2010). 
Nonetheless, the beef industry has managed to increase production by making strides in 
genetics, nutrition, health, and reproduction, as well as utilizing technologies such as 
anabolic implants and beta-agonists to produce more beef (Koontz, 2010). This has 
increased production per cow by 30% compared to cow production in 1980 (Koontz, 
2010) satisfying U.S. beef demand and export markets (Field, 2010).  
However, there is an expected 9 billion people to feed in the coming generation, 
and there will be fewer resources available for animal agriculture (Field, 2010; Godfray 
et al., 2010).  The majority of undeveloped land is expected to go to social and culture 
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needs due to the population growth, leaving less productive land for agricultural 
production (Godfray et al., 2010). Due to these expected production limitations, there is a 
need for continued research to discover areas for improvement in beef production. The 
following will be a review of the literature describing current feedlot cattle production in 
an attempt to discover possible areas for improvements.  
Anabolic Implants 
 Anabolic implants are utilized to alter metabolism from a state of catabolism 
towards anabolism resulting in increased protein synthesis, improved feed conversions, 
and possibly a reduction in carcass fatness (Lone, 1997). Currently, there are five FDA 
approved growth promoting steroids used in implants: estradiol (in the form of 17β-E2 or 
estradiol benzoate), progesterone, testosterone propionate, trenbolone acetate (TBA), and 
zeranol (Kolok and Sellin, 2008). Melengesterol acetate (MGA), a progestin, is another 
growth promoting steroid used as a feed additive to restrict females from cycling, as the 
estrus cycle causes disruptions in growth and loss of efficiency (Lone, 1997). The mode 
of action of implants and combination implants are well reviewed in Lone (1997), Webb 
et al. (2002), and Sillence (2004).  Implants have a direct effect on skeletal muscle 
accretion by altering protein synthesis and degradation, as well as indirectly increasing 
growth hormone and insulin-like like factor (IGF) concentrations, which lead to increases 
in muscle accretion (Lone, 1997; Webb et al., 2002; Sillence, 2004). Also, implants 
increase satellite cell recruitment and proliferation towards skeletal muscle (Webb et al., 
2002). Increased skeletal muscle growth with the use of implants translates to increased 
hot carcass weights (HCW) and longissimus muscle area (LMA) while increasing 
average daily gain (ADG) and feed efficiency compared to nonimplanted cattle (Johnson 
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et al., 1996; Bruns et al., 2005). Other than improvements in carcass traits, implants have 
improved growth rates in cattle (Bruns et al., 2005; Parr et al., 2011). Moreover, it is well 
understood implants have the capability of negatively altering quality grade, skeletal 
maturity, the occurrence of dark cutting beef (Webb et al., 2002) as well as tenderness 
(Nichols et al., 2002; Webb et al., 2002).  However, the effect implants have on these 
traits is highly variable depending on the type and aggressiveness of implants, breed, 
environmental conditions, stress, and timing of implant in relation to slaughter (Morgan, 
1997). 
Beta Adrenergic Agonists  
 Even though implants have been proven effective, researchers discovered another 
physiological mechanism to increase beef production through the use of beta-adrenergic 
agonists (βAA). Beta-adrenergic agonists mimic naturally occurring catecholamines: 
epinephrine, norepinephrine, and isoproterenol (Mersmann, 1998; Rathmann et al., 2012; 
Johnson et al., 2014a). Beta-adrenergic agonists work by attaching to beta-adrenergic 
receptors (βAR) located on the cell membrane, which activates a cascade of 
phosphorylation of numerous proteins (Johnson et al., 2014a). The overriding response is 
an increase in protein synthesis, a decrease in protein degradation (only associated with a 
few βAA), an increase in lipolysis, and a decrease in fatty acid biosynthesis (Mersmann, 
1998; Johnson et al., 2014a).   
 Ractopamine hydrochloride, Optaflexx®, and Zilpaterol hydrochloride, Zilmax®, 
are the two FDA approved βAA for cattle in the United States. Ractopamine 
hydrochloride has a higher affinity for βeta 1-Adrengenic receptors and causes an 
increase in protein synthesis (Mersmann, 1998). Zilpaterol hydrochloride, however, has a 
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higher affinity for βeta 2-Adrengenic receptors and elicits an increase in protein synthesis 
and decrease in protein degradation (Scramlin et al., 2010). Therefore, zilpaterol 
hydrochloride has a higher protein accretion rate resulting in heavier HCW and increased 
ADG compared to RAC (Johnson et al., 2014b). However, over recent years RAC is the 
only βAA being used by the cattle industry, because zilpaterol hydrochloride has been 
removed from the market because of animal welfare concerns (Johnson et al., 2014b).  
Nonetheless, typical results with the use of RAC include increased ADG (Gruber 
et al., 2007; Scramlin et al., 2010; Bohrer et al., 2014), feed conversion (Gruber et al., 
2007; Scramlin et al., 2010; Bohrer et al., 2014; Bittner et al., 2016), HCW (Gruber et al., 
2007; Scramlin et al., 2010; Bohrer et al., 2014; Bittner et al., 2016; Edenburn et al., 
2016), and LMA (Bittner et al., 2016). The magnitude of change for each trait with RAC 
is dependent on the dosage as discussed in Bittner et al. (2016). Nonetheless, the 
optimum dose for RAC supplementation is 200 mg of RAC/steer daily, regardless of 
supplement duration (Bittner et al., 2016).  
AS previously discussed, RAC has been shown to be a beneficial technology to 
meet beef demands. However, consumers have become wary of the technologies used in 
beef production, and a less invasive means of growth promotion has become more 
important. The addition of grains into diets of finishing cattle has been proven as a way to 
hasten growth compared to forage finished cattle.  
Grain finishing 
 Grain finishing started growing in popularity between 1945 – 1972 when there 
was a surplus of cheap grain (Field, 2010). Incorporating grains into finishing diets has 
continued because of the increased efficiencies of gain (Oltjen et al., 1971; Waldo, 1973; 
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Crouse et al., 1984), increased carcass weights (Crouse et al., 1984; Mandell et al., 1998; 
Berthiaume et al., 2006), and reduction of time on feed to reach market weights (Oltjen et 
al., 1971; Crouse et al., 1984; Muir et al., 1998).  Grain is generally more digestible 
versus forages, because there are a lower proportion of structural components (Church, 
1988). Structural components in plant matter reduce the production of ruminal volatile 
fatty acids (VFA), and VFAs are the main substrates the ruminant animal uses to produce 
energy (Church, 1988). Furthermore, grains have higher amounts of starch, which is more 
readily available to the animal, and this results in more energy available for growth 
verses maintenance (Church, 1988).. 
 Even though the use of grain in finishing diets has increased efficiencies, there is 
a growing evidence of insulin resistance developing in feedlot cattle. Recent data has 
shown increased insulin resistance the longer cattle are on a finishing diet (Kneeskern et 
al., 2016). As well, corn-based diets increased insulin resistance compared to diets 
consisting of either grass hay or dry distillers grain as the main energy sources (Radunz et 
al., 2012). The development in insulin resistance is thought to be similar to obesity-
induced insulin resistance occurring in human health. Therefore, an understanding of 
insulin function and insulin resistance is necessary to determine if growth can be 
augmented in feedlot cattle.  
Insulin Function and Resistance 
Insulin is a major metabolic regulator, as it stimulates nearly all the anabolic 
pathways; of glucose uptake, the synthesis and storage of carbohydrates, fats, and 
proteins (Sherwood et al., 2013). Furthermore, the presence of insulin conserves 
substrates from catabolism. The overall function of insulin is to promote storage when 
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nutrients are adequately supplied, however impairment to the insulin pathway can 
develop.  
Insulin resistance can be defined as a less than normal biological response to 
normal concentrations of insulin (Kahn, 1978). Insulin resistance can be due to decreased 
insulin sensitivity or responsiveness of the tissue or a combination of both. A reduction in 
insulin sensitivity means more insulin is required to elicit the same response, whereas 
reduced insulin responsiveness is a decrease in the maximum biological response to the 
same concentrations of insulin (Kahn, 1978; Muniyappa et al., 2008).  Insulin resistance 
can develop because of two general reasons. One reason is because the body is sparing 
glucose for higher priority tissues, such as the brain or fetus. This scenario is commonly 
observed in gestational diabetes (Vernon et al., 1990; Kerestes, 2009). Secondly, insulin 
resistance can develop because the cell is saturated with glycogen and is limiting the 
amount of nutrients coming into the cell.  This case is observed in a high-energy state and 
has been related to obesity-induced type 2 diabetes 
(Kahn et al., 2006). This review will focus on the 
latter scenario, as it is the logical cause of 
developing insulin resistance in feedlot steers.  
Insulin signaling propagates by binding to 
the extracellular α-subunit of the insulin receptor 
(IR), which leads to autophosphorylation of its β-
subunit (Patti and Kahn, 1998). As insulin 
phosphorylates itself it creates an active tyrosine 
kinase on the β-subunit allowing phosphorylation 
Figure 1.1. Insulin signaling and 
cellular affects downstream. 
Adapted from Vincent (2010). 
IRS-1PI3K
AKT
Insulin or IGF
Insulin Receptor
Vesicle 
GLUT 4
Glucose
Figure 1. Insulin Signaling 
Protein synthesis
Lipid synthesis
Glycogen synthesis
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of tyrosine residuals located on IR substrate proteins (IRS) (Vincent and Bennett, 2007). 
Activation of IRS proteins leads to the proliferation of the signaling cascade between IRS 
–> phosphotidylinositide 3-kinase (PI3K) –> protein kinase B (Akt) ultimately leading to 
increased glucose uptake because of the translocations of glucose transporter 4 (GLUT4) 
to the cell membrane (Shepherd and Kahn, 1999). This is shown in Figure 1.1 along with 
the cellular effects downstream of Akt.  
Insulin resistance in obese subjects develops as a result of increased non-esterified 
fatty acids, glycerol, and pro-inflammatory adipokines released from adipose tissue 
causing interruptions in insulin signaling (Kahn et al., 2006). The reduced insulin 
signaling leads to less GLUT4 translocation to the cell membrane and less glucose 
absorbed by the cell. The elevated levels of blood glucose elicit the pancreatic β-cells to 
sequester more insulin in order to compensate, leading to hyperinsulimia (Kahn et al., 
2006). Unless the insulin resistance is alleviated, then this cycle will continue until the 
pancreatic β-cells are unable to keep up with insulin demands, then the β-cells become 
dysfunctional resulting in reduced mass and secretion of the cells (Rutter et al., 2015). 
This is when non-insulin dependent diabetes mellitus (Type 2) transpires. However, cattle 
on feed are not diagnosed as type 2 diabetic most likely because they are on high-energy 
diets during a time of rapid growth, and cattle are slaughtered before damage to the 
pancreatic β-cells occurs. Nonetheless, as stated previously, cattle are becoming more 
insulin resistant the longer they are on feed, and necessitate the need for research towards 
improvements. Thus, the research area of Cr supplementation has grown in livestock 
animals to determine if insulin resistance can be mitigated.  
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Chromium Supplementation  
 Chromium is a mineral proposed to be essential for normal carbohydrate 
metabolism as there have been observations of Cr potentiating insulin signaling 
(Anderson, 1997). Chromium was first proposed an essential mineral in rats by Mertz and 
Schwarz (1959) and later in humans by Jeejeebhoy et al. (1977), and because of this 
research Cr was classified as essential. However, conclusions from original Cr research is 
concerning, because the lack of a “low” or deficient diet (Vincent and Bennett, 2007). 
Plus, Cr assays were proven to have contained significant Cr contamination (Vincent and 
Bennett, 2007). Further, the original Cr molecule, glucose tolerance factor (GTF), proved 
to be an artifact from acid hydrolysis of low molecular weight Cr binding substance 
(LMWCr) (Sumrall and Vincent, 1997). These issues contribute to the debate among 
researchers whether Cr is essential or not. Nonetheless, supplemental Cr has gained 
attention because of beneficial results related to glucose and nutrient metabolism, which 
will be discussed below.  
Chromium bioavailability and tissue accumulation  
 Chromium is a common element in the earth and is found primarily in two forms: 
trivalent Cr (+3) and hexavalent Cr (+6) (Cefalu and Hu, 2004). Trivalent Cr is the form 
behind carbohydrate metabolism and has a very low toxicity versus Cr (6+) (Cefalu and 
Hu, 2004). The form of Cr supplementation has proven to have different bioavailabilities. 
Lindemann et al. (2008) demonstrated in growing pigs that Cr tripicolinate had the 
highest bioavailability in comparison to Cr methionine, Cr yeast, and Cr propionate 
(CrPrp) with a linear decrease in availability among the listed sources. Also, Cr will 
accumulate in liver, kidney, spleen, and bones, but there is no appreciable accumulation 
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of Cr in muscle (Wallach, 1985; Anderson et al., 1996; Lindemann et al., 2008). 
Anderson et al. (1996) and Lindemann et al. (2008) demonstrated different 
bioavailabilities of organic sources of Cr, but overall Cr absorption is generally low at 0.4 
– 2.0% (Anderson and Kozlovsky, 1985). 
Proposed Biological Actions of Chromium  
When Cr is absorbed, it enters the blood stream, binds with transferrin, and is 
transported to the insulin dependent tissue (Vincent, 1999). Through endocytosis the 
transferrin-Cr complex is taken into the cell. Chromium is released from transferrin and 
then is available to bind to the apo-, or inactive, LMWCr, also known as chromodulin 
(Vincent, 1999). Four trivalent Cr molecules will bind to LMWCr resulting in the active 
form, or holo-LMWCr (Vincent, 1999), which is shown in figure 2. Once the LMWCr is 
activated, it will bind and increase phosphorylation of the IR (Vincent, 1999; Vincent, 
2000; Wang et al., 2005) as well as increasing phosphorylation of IRS (Wang et al., 
2005). It has already been discussed above how insulin stimulates the IR leading to the 
cascade between IRS-PI3K-Akt. Insulin or IGF-1 signaling resulted in phosphorylation 
of both Threonine 308 and Serine 473 on Akt (Alessi et al., 1996). Both sites were 
required for full activation of Akt, but these two sites are not dependent on each other for 
phosphorylation (Alessi et al., 1996). Phosphorylation at Thr308 is accomplished by Akt 
co-localizing with phosphoinositide-dependent kinase 1 (PDK1), which is recruited to the 
Insulin or IGF
Insulin 
Receptor
Tf
Tr-R
Cr
       Vesicle
Apo-LMCr
Holo-LMCr
Cr Cr
Cr Cr
       Vesicle
Tf
Tr-R
       Vesicle
Apo-LMCr
Tf
Cr
Tr-R
       Vesicle
Tf
Cr
Tr-R
Apo-LMCr
Figure 1.2. The proposed mechanisms of LMWCr with the insulin receptor. Adapted from 
Vincent (2000). 
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cell membrane by PI3K (Alessi et al., 1997). Phosphorylation on Ser473 is proposed to 
be caused by various proteins in addition to insulin (Song et al., 2005). Chromium 
supplementation in obese, insulin resistant mice resulted in increased phosphorylation at 
Ser473 when stimulated with insulin (Chen et al., 2009a). Once fully active, Akt is 
responsible for either inhibiting or activating several proteins associated with 
metabolism, proliferation, growth, angiogenesis, glucose uptake, and cell survival 
(Manning and Cantley, 2007).  
Downstream of Akt lies the mammalian target of rapamycin (mTOR) signaling 
protein and the mTOR complex (mTORC1), which is responsible for the integration of 
cellular signaling and the transduction of further responses (Laplante and Sabatini, 2009). 
Protein kinase B (Akt) inhibits the tumor sclerosis complex (TSC), which in turn reduces 
TSC’s inhibitory regulation on mTOR (Inoki et al., 2002). Ribosomal protein S6 kinase 1 
(p70S6K), is involved in regulation of protein synthesis, and is phosphorylated by Akt 
because of increased insulin signaling (Inoki et al., 2002). Ribosomal S6 kinase 1 is also 
activated by mTORC1 (Laplante and Sabatini, 2009). This demonstrates mTOR and 
mTORC1 are downstream targets of insulin, and could be a potential target of Cr 
supplementation.  
Further evidence of Cr influencing insulin signaling and responsiveness has been 
observed through the interaction with glucose transporters. The IRS-PI3K-Akt pathway 
causes GLUT4 to move from the cytoplasm to the cell membrane (Gomperts et al., 
2004). GLUT4 will then translocate glucose from the blood stream into the cell to be 
utilized for metabolism (Hadley and Levine, 2007). Increases in membrane-associated 
GLUT4 were observed with Cr picolinate after insulin tests in obese rats (Cefalu et al., 
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2002), as well as in cell culture with adipocytes (Chen et al., 2006). Furthermore, Cr has 
increased GLUT4 translocation to the cell membrane by a cholesterol induced 
mechanism (Pattar et al., 2006; Sealls et al., 2011).  Sterol regulatory element-binding 
protein (SREBP) was upregulated with Cr supplementation, which is responsible for 
controlling cellular cholesterol balance (Pattar et al., 2006). Sterol regulatory element-
binding protein is regulated by the mTORC1 complex (Laplante and Sabatini, 2009). 
Therefore, Cr could be modifying cholesterol balance by increased activation of IRS 
and/or Akt leading to increased activation of mTORC1 and resulting in increased SREBP 
in addition to increased GLUT4 translocation.  
Other note worthy actions of insulin include increased PI3K activity, which also 
results in increased absorption of amino acids and lipids (Gomperts et al., 2004). As well, 
insulin results in up regulation of lipoprotein lipase and GLUT4 transcription (Gomperts 
et al., 2004). Lipoprotein lipase is responsible for cleaving fatty acids from chylomicrons, 
which transport fatty acids from the liver to target tissues, allowing for the fatty acids to 
be utilized for storage or energy metabolism in the cell (Hadley and Levine, 2007). 
 Thus, Cr supplementation could lead to more active LMWCr allowing for 
amplification of insulin signaling, ultimately resulting in a faster and more efficient use 
of metabolites. Therefore, Cr research has increased as its role in normal physiology and 
the potential for improving or alleviating metabolic disorders has been identified.  
Chromium supplementation in Human Health  
 The case for Cr being essential for humans was stemmed from a patient receiving 
total parenteral nutrition (TPN). The patient started showing severe signs of diabetes, 
weight loss, and hyperglycemia, but symptoms were completely reversed when 
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supplemented Cr (Jeejeebhoy et al., 1977). This study, as well as other TPN studies 
(Freund et al., 1979; Brown et al., 1986; Tsuda et al., 1998), suggests Cr is necessary for 
proper insulin signaling. This has lead to research examining if Cr could improve 
impaired or normal glucose metabolism.  
Human studies have generally consisted of type 2 diabetics, because they are 
insulin resistant and this is a major health concern in the US. Also, studies have included 
the elderly as they have impaired glucose metabolism, and adults with normal insulin 
metabolism. The majority of research shows Cr can improve aspects of glucose 
metabolism related to insulin resistance as well as age (Glinsmann and Mertz, 1966; Nath 
et al., 1979; Offenbacher and Pi-Sunyer, 1980; Roeback et al., 1991; Anderson et al., 
1997). Chromium has also decreased blood insulin levels and total cholesterol levels in 
patients with normal insulin metabolism (Urberg et al., 1988; Wang et al., 1989; Press et 
al., 1990; Lefavi et al., 1993; Anderson et al., 1997). However, there are studies that are 
inconsistent with these, as they reported no effects of supplemental Cr improving glucose 
metabolism with Type 2 Diabetes Mellitus (Sherman et al., 1968; Rabinowitz et al., 
1983; Thomas and Gropper, 1996), or in adults with normal metabolism (Glinsmann and 
Mertz, 1966; Thomas and Gropper, 1996). Anderson (1998) suggested the variation 
between studies is due to varying degrees of glucose intolerance, diet, duration, and type 
and amount of Cr supplementation. Additionally, response to Cr is reduced by stress 
(Kegley et al., 1996; Anderson, 1998) and absorption is reduced by simple sugars in the 
diet (Kozlovsky et al., 1986). All of these issues add variation to human studies making it 
difficult to form a conclusion about Cr supplementation, but Cr appears to be beneficial 
in improving impaired glucose metabolism.  
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Cr supplementation in Livestock 
 The majority of research leading to the theory Cr is an essential nutrient was 
conducted on rodents. From the results, it led researchers to question if Cr is adequately 
supplied to livestock species, and whether or not production would improve with 
supplementation.  
Cr supplementation in swine 
Chromium research among livestock species was first conducted in swine 
production. There has been mixed results in live performance as Matthews et al. (2003; 
2006) did not see differences of CrPrp supplementation at 200ppb on ADG, average daily 
feed intake (ADFI), and gain to feed (G:F) when fed to growing-finishing pigs. Page et 
al. (1993) reported improved G:F and an increase in ADFI with Cr picolinate at 200 ppb. 
However, Lindemann et al. (2008) used four different Cr supplements (Cr tripicolinate, 
CrPrp, Cr methionine, and Cr yeast) and reported improved G:F during the middle and 
late phases of finishing; as well as improved ADG in the late phase of growth when 
supplemented 5,000 µg of Cr/kg. Kornegay et al. (1997) observed improved dry matter 
digestibility and nitrogen absorption when supplementing 200 ppb Cr picolinate, but no 
other improvements in live animal performance. Amoikon et al. (1995) supplemented 
200 µg of Cr/kg of diet as Cr and observed no differences in growth performance, but 
observed increased insulin sensitivity as glucose disappearance rates were increased with 
supplementation. Furthermore, blood metabolites were altered, as there were decreased 
levels of non-esterified fatty acids (NEFA) and increased fasting cholesterol levels with 
Cr supplementation. However, Page et al. (1993) observed mixed results in ADG 
between three experiments as  Exp. 1 had increased ADG, Exp. 2  ADG  was decreased, 
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and Exp. 3 there was no difference. Furthermore, Page et al. (1993) observed no 
difference between experiments on blood metabolites or serum insulin levels.  
Investigators have also examined the effects of supplemental Cr on carcass 
performance with the same variability observed in live animal performance. Lindemann 
et al. (2008) observed no difference in LMA or BFT, but this is contrary to Matthews et 
al. (2003; 2006) and Mooney and Cromwell (1995; 1997). Kornegay et al. (1997) 
observed no changes in dressing percentage or backfat thickness at the last rib or 10th rib, 
however LMA was increased with Cr supplementation. Page et al. (1993) and Lindemann 
et al. (1995) observed reduced backfat and increased LMA. Moreover, percent muscle 
was increased (Page et al., 1993; Mooney and Cromwell, 1995; Jackson et al., 2009) and 
percent carcass fat was decreased (Mooney and Cromwell, 1995) with Cr 
supplementation.  
 There have been indications of increased water holding capacity with Cr 
supplementation. Lindemann et al. (2008) reported a decrease in cooler shrink in hogs 
supplemented with Cr supplementation.  Furthermore, there has been decreases in purge 
loss (Matthews et al., 2006), thaw loss (Matthews et al., 2003),  and cook loss (Shelton et 
al., 2003) in loin chops from Cr supplemented animals. 
Other pork quality traits have been measured, but with more variability in results. 
Minolta a* and b* values were decreased at day 1 in Lindemann et al. (2008), but by day 
5 these color differences diminished. Furthermore, Matthews et al. (2003); (2006) did not 
see any differences in color. Matthews et al. (2003); (2006); Lindemann et al. (2008) 
found no differences in pH between Cr supplementation and control. Matthews et al. 
(2006) did not report differences in marbling score, but Matthews et al. (2003) reported 
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Cr supplementation increased subjective marbling. Percent intramuscular fat was not 
measured in Matthews et al. (2003), but percent moisture was decreased with Cr 
supplementation. The researchers suggested this confirms the subjective marbling 
difference, because marbling and moisture are inversely related.   
As it can be inferred from the previous literature, there is considerable variability 
in growth, carcass, and meat quality traits in swine when given Cr supplementation. This 
lead Sales and Jancik (2011) to conduct a meta-analysis of the existing research.  The 
results from the analysis concluded Cr supplementation decreases fat deposition, 
increases muscle deposition, and improves gain to feed, but had no affect on meat quality 
(Sales and Jancik, 2011).  
Cr supplementation in Cattle 
 As a result of the discoveries of Cr supplementation in rodents, there has been an 
interest to determine if cattle would have improved growth. The majority of Cr related 
research has been performed on beef calves during the receiving period or with dairy 
cattle. Little research has been conducted on finishing cattle to determine if there would 
be similar alterations in carcass tissues as noticed in swine production.   
 Glucose tolerance tests provided indications that Cr could have an affect on 
insulin sensitivity in cattle.  In a study conducted on Angus and Angus x Simmental 
heifers, data revealed CrPrp supplementation increased insulin sensitivity (Spears et al., 
2012). Heifers supplemented with CrPrp in this study had lower serum insulin 
concentrations, lower molar insulin to glucose ratio, and the area under the glucose 
response curve was lower compared to controls (Spears et al., 2012). In a study with 
Holstein bull calves, Cr supplementation lowered plasma glucose concentrations after 
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intravenous infusion of insulin, indicating an improved insulin response with Cr (Kegley 
et al., 1997).  Improved insulin responsiveness is also supported by a study with pregnant 
Angus and Simmental cows. Cows supplemented with Cr had lowered plasma glucose, 
insulin, and NEFA concentrations after glucose tolerance testing (Stahlhut et al., 2006). 
Furthermore, Sumner et al. (2007) also observed improved glucose utilization by growing 
dairy heifers with Cr supplementation. When it comes to glucose tolerance tests in feedlot 
cattle, it has been shown cattle become more insulin resistant with increased days on feed 
(Radunz et al., 2012; Kneeskern et al., 2016). However, this developing insulin resistance 
was not mitigated by Cr supplementation in previous research (Kneeskern et al., 2016). 
Nonetheless, this is the only glucose tolerance test (GTT) data for feedlot cattle 
supplemented Cr and this area of research warrants further investigation.  
 As stated previously, there is little research on Cr supplementation in feedlot 
cattle. Within the published literature, live growth performance has been similar with Cr 
supplementation in feedlot cattle (Chang et al., 1992; Guifen et al., 2011; Bohrer et al., 
2014; Sánchez-Mendoza et al., 2014; Edenburn et al., 2016; Kneeskern et al., 2016). Yet, 
Pollard et al. (2002) observed reductions in G:F and ADG with 0.4 ppm Cr yeast 
supplementation compared to control and 0.2 ppm Cr, but no difference between control 
and 0.2 ppm.  
Unlike the live performance, Cr supplementation has resulted in changes in 
carcass and meat quality traits, however the data is highly variable. Pollard et al. (2002) 
observed the heaviest HCW for 0.2 ppm Cr, the lightest HCW for 0.4 ppm Cr, and 
control was intermediate. Control and 0.2 ppm Cr were not different for DP, yield grade, 
or marbling. However, 0.4 ppm Cr had lower dressing percent and lower marbling score, 
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but higher yielding carcasses (Pollard et al., 2002). The difference in yield grade is 
presumed to be due to the decrease in HCW as there was no difference between LMA 
and backfat thickness was not reported. Sánchez-Mendoza et al. (2014) reported larger 
LMA as well as trends for both a decrease in backfat thickness and higher retail yields 
with 500 ppb Cr yeast. However, Chang et al. (1992) found no difference in HCW, DP, 
LMA, marbling, KPH, or 9-10-11 rib composition estimates with 0.2 mg Cr yeast/kg. 
Similarly, carcass data from Guifen et al. (2011) and Danielsson and Pehrson (1998) 
were unchanged with Cr supplementation. Yet, Cr resulted in a decrease in the percent of 
high-grade cuts using China’s quality grading system (Guifen et al., 2011).   
Of the data discussed above, only the studies by Bohrer et al. (2014); Edenburn et 
al. (2016); and Kneeskern et al. (2016) use CrPrp, which is the only approved form of 
supplemental Cr for beef cattle in the US.  Bohrer et al. (2014) and Edenburn et al. (2016) 
have the only published data using RAC and CrPrp. The CrPrp treatment occurred during 
the last 30 – 60 d prior to slaughter with the RAC supplement. Whereas, Kneeskern et al. 
(2016) started with 246 kg steers supplemented for 134 – 174 d, depending on when 
target backfat thickness was reached, and RAC was not used in this study.  
Nonetheless, all three studies found no difference in live animal performance, 
HCW, LMA, backfat thickness, or yield grade. Yet, Kneeskern et al. (2016) observed a 
1.3% increase in dressing percentage. It should be noted statistical difference was at P ≤ 
0.10 in Edenburn et al. (2016). Bohrer et al. (2014) observed a trend for a decrease in the 
percentage of carcasses grading Low Choice in steers supplemented CrPrp, and Edenburn 
et al. (2016) reported a trend for an increase in the percent of carcasses grading Select 
from steers supplemented CrPrp. Furthermore, Bohrer et al. (2014) and Edenburn et al. 
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(2016) observed no differences in WBSF, cook loss, pH, a*, or b* results. Chromium 
supplementation, however did increase L*(lightness of muscle), but information on how 
Cr could affect L* is unknown (Edenburn et al., 2016).  
Conclusion  
There is not enough literature with fed cattle to conclude if Cr could be a 
beneficial nutritional supplement, especially with current production practices utilized 
today. The variation that exists in observations can be attributed to various forms of 
supplement, dose, duration, stress (metabolic and/or environmental), growth stage when 
animals started supplement, inherent level of Cr in the diet, and the biological need of Cr 
by the animal. Other than type, dose, and duration, the other factors are uncontrollable, 
and contribute to the biological variation innate with animal studies. Thus, more research 
is needed to determine whether Cr is a beneficial nutritional supplement. Furthermore, 
implants and beta-agonists alter normal physiology and the influence of Cr with these 
technologies is yet to be determined. Thus, we chose to conduct the following studies in 
fed cattle supplemented with Cr to determine if Cr altered the signaling pathways 
downstream of insulin in muscle tissue. 
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CHAPTER 2 
THE INFLUENCE OF CHROMIUM SUPPLEMENTATION ON THE INSULIN 
PATHWAY, CARCASS TRAITS, AND MEAT QUALITY OF FEEDLOT 
STEERS 
 
INTRODUCTION 
 Chromium (Cr) had been accepted as an essential nutrient for animals (Mertz and 
Schwarz, 1959) and humans (Jeejeebhoy et al., 1977) because Cr is proposed to be 
essential for normal insulin metabolism (Anderson, 1997). Research has demonstrated 
supplemental Cr can improve insulin sensitivity in some, but not all, human patients 
exhibiting insulin resistance (Anderson, 1998). Cattle have a lower insulin response in 
insulin-dependent tissues and therefore are more insulin resistant compared to 
monogastrics (Koster and Opsomer, 2013). Improving insulin sensitivity could lead to 
increased utilization of nutrients by insulin dependent tissues, possibly translating to 
increased growth of carcass tissues. There is limited research focusing on Cr 
supplementation in finishing beef cattle and the effect on beef carcass traits. Barajas et al. 
(2008) and Song et al. (2013) observed increases in HCW in steers supplemented Cr as 
Cr methionine. Kneeskern et al. (2016) reported increased dressing percentage (DP) with 
Cr propionate, and Sánchez-Mendoza et al. (2014) observed an increase in longissimus 
muscle area (LMA) in steers supplemented Cr yeast. Additionally, a cell culture study by 
Tokach et al. (2015) indicated Cr supplementation improved adipogenesis of 
intramuscular adipocytes (IMF) when cells were exposed to Cr propionate, and indicated 
Cr could increase marbling in finishing beef cattle. Thus, we hypothesized Cr 
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supplementation would increase tissue utilization of nutrients due to amplified insulin 
signaling resulting in improvements in HCW, DP, LMA, and marbling. Therefore, our 
objective was to determine the effect Cr supplementation on carcass characteristics, meat 
quality, and signaling factors downstream of the insulin pathway. 
 
MATERIALS AND METHODS 
 South Dakota State University Animal Care and Use Committee approved all 
procedures involving live animals in this study.  
Exp. 1 
Animal Care and Use 
 Angus steers from a single source (n = 28; BW = 289 kg ± 12 kg) were received 
at the Ruminant Nutrition Center (Brookings, SD). Steers were allotted to a pen by BW 
and randomly assigned a treatment resulting in 2 pens/treatment with 7 steers/pen. 
Treatment diets consisted of 0 ppb added Cr (CON) or 400 ppb added Cr supplemented 
as Cr propionate (Cr400, KemTRACE 0.4% Chromium Propionate; Kemin Industries, 
Des Moines, IA). Receiving protocol and basal diet is recorded in Smith (2015).  
Supplementation of Cr400 began on d 4 of the trial and continued until slaughter. 
Supplement formulation is provided in Table 1 and the composition of diets fed for the 
finishing phase are provided in Table 2. Cattle received Synovex-Plus as the terminal 
implant (Zoetis, Florham Park, NJ) on d 123. A subset of cattle (n = 5/pen) closest to the 
mean ADG for each pen was selected for muscle biopsies. Following the terminal 
implant, the first LM biopsy was collected on d 184 (biopsy184) posterior to the 13th rib 
and approximately 5.08 cm ventral to the spine on the right side. Lidocaine® was 
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administered as a local anesthetic followed by a 2.54 cm incision. Jackson uterine biopsy 
forceps (Jorgenson Labs, Loveland, CO) were used to collect muscle tissue. Tissue 
samples were snap frozen in liquid nitrogen and stored at -80°C. Steers started 200 
mg/hd/d ractopamine hydrochloride (RAC; Optaflexx 45®; Zoetis, Florham Park, NJ) on 
d 185. During supplementation of RAC, the second LM biopsy was collected on d 200 
(biopsy200) following the same procedure but approximately 5.08 cm posterior to 
biopsy184 location. Two steers were removed from the study because of foot rot resulting 
in 12 steers in the CON and 14 steers in Cr400.  
Carcass data and sample collection 
Cattle were weighed off test on d 210, and then transported approximately 240 km 
to a commercial packing facility (Tyson Foods, Inc. Dakota City, NE). Cattle were 
tracked throughout harvest to maintain identity. Following carcass chilling 
(approximately 28 h), LMA, 12th rib back fat (BF), HCW, KPH, marbling score, skeletal 
maturity, and lean maturity were collected on the left side of the carcass by trained 
personnel. The average of two objective color score measurements (Minolta colorimeter, 
Konica Minolta, Ramsey, NJ) were obtained within the LM for L*, a*, and b* values 
after approximately one hour of bloom time. A subset of carcasses (n = 3/pen) closest to 
the mean ADG for each pen was selected for carcass composition estimation. Rib 
sections were marked for rib-plate separation as outlined for 9-10-11 rib dissection in 
Hankins and Howe (1946). Strip loins (n = 26, IMPS 180) and wholesale ribs (n = 12, 
IMPS 103) from the left side were tracked through fabrication, and transported under 
refrigeration to South Dakota State University Meat laboratory for further processing. 
Carcass and quality data were collected from a dark cutter in the CON treatment, but this 
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sample was excluded from LM quality measurements, 9-10-11 rib composition, WBSF, 
and cook loss analyses. Approximately 3 d postmortem, strip loins were denuded and the 
first steak was removed for proximate analysis and pH determination. Steaks were frozen 
at -20°C until analyses. Three steaks (2.54 cm) were cut starting from the anterior end of 
each strip loin, and were allotted sequentially for Warner-Bratzler shear force (WBSF) at 
6, 14, and 21 d postmortem. Steaks were refrigerated (1.7 - 4.4°C) until the designated 
aging period was reached and then frozen at -20°C until WBSF could be performed. 
Wholesale ribs were fabricated into 9-10-11 rib sections according to Hankins and Howe 
(1946) and weighed. Then soft tissue was separated from bone and cartilage and weighed 
separately. Soft tissue was homogenized using a bowl chopper (Model CM-14, Manica, 
St. Louis, MO), vacuumed packaged, and stored at -20°C for proximate analysis 
according to Mohrhauser et al. (2015). 
Warner-Bratzler Shear Force and Cook loss 
All steaks were thawed at 4°C for 12 h and then tempered to room temp for 12 h. 
Steaks were weighed prior to cooking, cooked to an internal temperature of 71°C at the 
geometric center using clamshell grills (George Forman, Model GR2144P, Middleton, 
WI), and weighed after cooking. Peak internal temperature was recorded using calibrated 
hand held digital thermometers (Atkins Aqua Tuff thermometers, Cooper-Atkins 
Cooperation, Middlefield, CT). Steaks were allowed to cool in refrigeration until internal 
temperatures were below 4°C. Six cores (1.27 cm-diameter) were removed running 
parallel to the muscle fibers and sheared perpendicular to fiber orientation with a Warner-
Bratzler shear machine (G-R Electric Manufacturing Company, Manhattan, KS) 
equipped with a Mecmesin 500N basic force gauge (Mecmesin Ltd., West Sussex, United 
 
 
23 
kingdom). Peak force (kg) was recorded for each core and an average was calculated 
using the values of 6 cores for each steak. Cook loss was determined as the percent 
difference between fresh and cooked weight using the following equation. 
!""# !"##,% = !"#$ℎ !"#$ℎ!,! −  !""#$% !"#$ℎ!,!!"#$ℎ !"#$ℎ!,!  × 100 
Proximate Analysis and Carcass Composition Estimation 
  The first steak from each strip loin was designated for ether extraction. Steaks 
were allowed to thaw slightly, minced, frozen in liquid nitrogen, and powered in a 
Waring commercial blender (Waring Products Division, New Hartford, CT). Powdered 
samples were stored at -20°C for subsequent extraction. Approximately 5 g of sample 
was dried in pre-weighed aluminum tins and filter paper in a drying oven (Thelco 
Laboratory Oven, Precision Scientific, Winchester, VA) at 100°C for 24 h. Samples were 
reweighed, and were extracted for fat with petroleum ether in a side-arm soxhlet (AOAC, 
1990) for 60 h. Following extraction excess ether was allowed to evaporate under a fume 
hood for approximately an hour. Then samples were dried an additional 24 h at 100°C 
before final weighing. Fat content was calculated as the difference between dried and 
extracted weight. 
Proximate analysis was performed on the soft tissue portion from the 9-10-11 rib 
sections. Water and fat content were determined using the same procedure outlined for 
ether extraction. Protein content was determined by weighing approximately 200 mg of 
sample into nitrogen free foil tins and placed in an Elementar nitrogen analyzer (Rapid N 
III, Hanau, Germany). Ash content was determined by placing approximately 3 g of 
sample into pre-weighed crucibles, dried at 100°C for 24 h, and heated in a muffle 
furnace (Isotemp Programmable Muffle Furnace, Fischer Scientific, Waltman, MA) at 
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500°C for 16 h. All samples were repeated in duplicate. The chemical data from 
proximate analysis of 9-10-11 ribs was used to estimate carcass soft tissue composition 
using equations in Hankins and Howe (1946). Estimated soft tissue composition was then 
used to calculate total carcass composition for bone and soft tissue (Hankins and Howe, 
1946).  
pH Determination  
 Ten grams from the powdered steak samples were homogenized in 90 mL of 
distilled water using an Ultra Turrax homogenizer (IKA, Model T25DS1, Germany).  
Ultimate postmortem pH was determined using a Thermo Orion PerpHecT LogRmeter 
model 330 (Thermo Scientific, Beverly, MA) as described by Kern et al. (2013).  
Real-Time PCR 
 Muscle biopsy samples were thawed and approximately 50 mg of tissue was 
removed under sterile conditions. Samples were placed in bead beater tubes containing 
700 µL of QIAzol Lysis Reagent provided in the Qiagen miRNeasy mini kit (Hilden, 
Germany). RNA extraction was completed according to the methodology and buffers 
provided in the Qiagen miRNeasy mini kit, and the method is outlined below. Samples 
were homogenized using a PowerLyzer® 24 (Mo-Bio Laboratories, Inc., Carlsbad, CA) 
for 45 s, 30 s dwell, and 45 s at 3500 x g. Homogenized tissue lysates were held at room 
temperature for approximately 5 min to promote disassociation of nucleoprotein 
complexes. 140 µL of chloroform was added to samples, shaken vigorously for 15 s, then 
held at room temperature for approximately 2 min. Samples were centrifuged at 12,000 x 
g at 4°C for 15 min to achieve phase separation; upper RNA aqueous phase, white 
interphase, and lower red organic phase. The RNA aqueous phase, approximately 450 
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µL, was transferred to a new collection tube and mixed with 1.5 volumes of ethanol. 
Then the RNA aqueous phase sample was pipetted into a filter tube and centrifuged at 
8,000 x g for 15 s at room temperature. 700 µL of Buffer RWT was added to the samples 
and filtered by centrifuging at 8,000 x g for 15 s at room temperature. Followed by 
pipetting 500 µL of Buffer RPE to the samples and filtered by centrifuging at 8,000 x g 
for 15 s at room temperature. Samples were washed again with Buffer RPE and 
centrifuged at 8,000 x g for 2 min at room temperature. RNA was eluted from filter tube 
with 50 µL of RNase-free water and centrifuging at 8,000 x g for 1 min at room 
temperature. Filtrated RNA sample was pipetted into a RNA free micro-centrifuge tube, 
and total nucleic acid content was estimated using a Nanodrop 2000 spectrophometer 
(Thermo Scientific, Wilmington, DE). Samples were diluted to 200 ng/µL RNA with 
RNase-free water and stored at -80°C. 
 RNA was converted to cDNA using a high capacity cDNA reverse transcriptase 
kit (Applied Biosystems, Foster City, CA) and PCR was performed using a MyCycler 
thermal cycler (Bio-Rad Laboratories, Hercules, CA). Real-time quantitative PCR was 
performed using SYBER Green real time PCR, and samples were ran in triplicate. 
Primers used were published in Takahashi et al. (2014) and Kern et al. (2014) and listed 
with primer sequences and accession numbers in Table 3. Primers were diluted in 400 µL 
of RNase-free water. A master mix was made containing SYBER Green, forward primer, 
reverse primer, and RNase-free water. Twenty-five µL of master mix was added to each 
well resulting in 12.5 µL of SYBER Green, 9.5 µL water, 1 µL forward primer, and 1 µL 
reverse primer. Real time polymerase chain reaction was conducted using a Stratagene 
Mx3005P (Agilent Technologies, Santa Clara, CA) with cycle settings in three segments, 
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Segment 1: 1 cycle of 95°C for 10 min; Segment 2: 40 cycles of 95°C for 30 s, 55°C for 
1 min, and 72°C for 1 min; Segment 3: 1 cycle of 95°C for 1 min, 55°C for 30 s, and 
95°C for 30 s.  
Western Blot  
Muscle biopsy samples were thawed and approximately 75 mg of tissue was 
removed, placed in 50 mL centrifuge tube, and held in -20°C while further extractions 
continued. Homogenizing solution [5 mM NaH2PO4, 1 mM (Na2HPO4)7H2O, 69 mM 
SDS] was added at 25 times the tissue weight followed 60 s of homogenization using 
Ultra Turrax homogenizer (IKA, Model T25DS1, Germany). Homogenized samples were 
held at -20°C while remaining samples was homogenized. Samples were warmed prior to 
centrifuging at 1,500 x g for 15 min at room temperature. The supernatant was transferred 
to new 15 mL tube, and stored -80°C while protein concentration was being determined 
using the RC/DC Protein assay (based on Lowry’s assay, Bio-Rad Laboratories, 
Hercules, CA). Samples were then diluted to 2.5 mg/mL with distilled water. Equals parts 
of sample loading buffer [150 mM Tris-HCl (pH 6.8), 20% (vol/vol) glycerol, 0.004% 
(wt/vol) bromophenol blue] and diluted samples were added followed by denaturing the 
sample on a heat blocker at 100°C for 5 min. Samples were then stored at -80°C until 
western blotting. Mercaptoethanol was added at 6% to samples followed by subsequent 
heating at 100°C for 5 min.  
PPAR 
Samples (10 µL) were loaded onto a 15% tris-hydrochloride gels (Criterion 
Precast gels, Bio-Rad Laboratories, Hercules, CA) exposed to SDS-gel electrophoresis 
for 90 min at 200 V using the Bio-Rad Criterion Cell system (Bio-Rad Laboratories, 
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Hercules, CA). Gels were equilibrated in transfer buffer [25 mM Tris (pH 8.3), 192 mM 
glycine, 15% vol/vol methanol] for approximately 30 min and then transferred onto 
polyvinylidene difluoride (PVDF) membranes for 60 min at 90 V using a Criterion 
blotter system (Bio-Rad Laboratories, Hercules, CA). Membranes were equilibrated in 
Tris buffer saline [50 mM Tris-HCl (pH 7.6), and 150 mM NaCl] (TBS) and blocked in a 
solution containing equals parts TBS and Odyssey Blocking Buffer/TBS (OBB, Li-Cor 
Biosciences, Lincoln NE) one hour at room temperature. Membranes were then incubated 
for one hour at room temperature in primary antibody solution containing 1:100 dilution 
of anti-PPARγ goat (Santa Cruz Biotechnology, sc-1984), 1:8,000 dilution of anti-actin 
rabbit (Sigma Aldrich, A5060) in equal parts TBST [TBS + 0.1% Tween-20] and OBB 
while rocking. After incubation, membranes were rinsed with 20 mL TBST followed by 
5 min washes with 10 mL TBST repeated 4 times. Membranes were labeled with 
secondary antibody solution containing 1:20,000 dilution of donkey-anti-goat and 
donkey-anti-rabbit (Li-Cor Biosciences, Lincoln, NE) in TBST:OBB for one hour at 
room temperature while rocking. Membranes were rinsed with 20 mL TBST followed by 
four 5 min washes with 10 mL TBST.  
Akt and phospho-Akt (Ser473) 
Samples (10 µL) were loaded onto a 4-20% tris-hydrochloride gel (Criterion 
Precast gels, Bio-Rad Laboratories, Hercules, CA) exposed to SDS-gel electrophoresis 
for 90 min at 200 V using the Bio-Rad Criterion Cell system (Bio-Rad Laboratories, 
Hercules, CA). Gels were equilibrated in transfer buffer for approximately 30 min and 
then transferred onto either nitrocellulose (Akt) or PVDF membranes (phospho-Akt) for 
90 min at 90 V using a Criterion blotter system (Bio-Rad Laboratories, Hercules, CA). 
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Membranes were dried for an hour, rewetted in TBS for 15 min, and then blocked in 
TBS:OBB for one hour at room temperature. Membranes were then incubated overnight 
at 4°C in primary antibody solution containing either 1:100 dilution of anti-akt1/2/3 (H-
136) rabbit or anti p-Akt (ser473) rabbit (Santa Cruz Biotechnology, sc-8312 or sc-7985 
respectively), and 1:8,000 dilution of anti-actin mouse (Sigma Aldrich, A4700) in 
TBST:OBB while rocking. After incubation, membranes were rinsed with 20 mL TBST 
followed by 5 min washes with 10 mL TBST repeated 4 times. Membranes were labeled 
with secondary antibody solution contained 1:20,000 dilution of goat-anti-rabbit and 
goat-anti-mouse (Li-Cor Biosciences, Lincoln, NE) in TBST:OBB for one hour at room 
temperature while rocking. Membranes were rinsed with 20 mL TBST followed by four 5 
min washes with 10 mL TBST.  
p70S6K 
Samples (10 µL) were loaded onto a 4-20% tris-hydrochloride gel (Criterion 
Precast gels, Bio-Rad Laboratories, Hercules, CA) exposed to SDS-gel electrophoresis 
for 90 min at 200 V using the Bio-Rad Criterion Cell system (Bio-Rad Laboratories, 
Hercules, CA). Gels were equilibrated in transfer buffer for approximately 30 min and 
then transferred onto nitrocellulose membranes for 90 min at 90 V using a Criterion 
blotter system (Bio-Rad Laboratories, Hercules, CA). Membranes were dried for an hour, 
rewetted in TBS for 15 min, then blocked in TBS + 5% bovine serum albumin (BSA) 
(Sigma Aldrich, A3059) for one hour at room temperature. Membranes were then 
incubated overnight at 4°C in primary antibody solution containing 1:1000 dilution of 
anti-p70S6K rabbit (Cell Signaling Technology, 9202) in TBST + 5% BSA while 
rocking. Rinsed with 20 mL TBST followed by 5 min washes with 10 mL TBST repeated 
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4 times. Labeled with secondary antibody solution contained 1:20,000 dilution of goat-
anti-rabbit in TBST + 5% BSA. Membranes were rinsed with 20 mL TBST followed by 
four 5 min washes with 10 mL TBST. Membranes were then scanned before incubation 
of actin antibody. Following the initial scan membranes were then incubated with 
primary antibody solution with 1:8,000 dilution of anti-actin mouse (Sigma Aldrich, 
A4700) in TBST + 5% BSA for one hour at room temperature while rocking. After 
incubation, membranes were rinsed with 20 mL TBST followed by 5 min washes with 10 
mL TBST repeated 4 times. Membranes were labeled with secondary antibody solution 
contained 1:20,000 dilution of goat-anti-mouse in TBST + 5% BSA for one hour at room 
temperature while rocking. Membranes were rinsed with 20 mL TBST followed by four 5 
min washes with 10 mL TBST.  
Quantification of Western Blots 
Proteins were visualized and quantified using a Li-Cor Odyssey scanner (Lincoln, 
NE). Relative abundance of target proteins was determined by normalizing relative 
intensities of target protein to relative intensities of actin. Then to account for differences 
in transfer efficiency, relative abundance of target proteins were then standardized to a 
reference sample, which was run on each gel.  
Exp. 2 
Animal Care and Carcass Collection 
 The study was comprised of 256 heavy yearling steers (BW = 405 kg) divided 
into pens by BW, and then allocated to a dietary treatment of either 0 ppb Cr (CON) or 
300 ppb supplemented Cr (Cr300; KemTRACE, 0.4% Chromium Propionate; Kemin 
Industries, Des Moines, IA) resulting in 16 pens of 8 steers/treatment. Supplement 
 
 
30 
formulation is provided in Table 4 and the composition of diets fed in the finishing phase 
are provided in Table 5. Cattle were implanted with Synovex Choice on d 1 and Cr300 
started on d 9. Cattle were re-implanted with Synovex Choice on d 77, and started RAC 
on d 105 at a target of 300 mg/hd/d. Cattle were weighed off test the morning of d 138 
and shipped to a commercial packing facility (240 km; Tyson Foods, Inc. Dakota City, 
NE). A subset of steers (1 steer / pen; n = 32) closet to the ADG pen mean were chosen 
as the subsample to collect carcass data and strip loins. Animal identity was tracked 
through harvest and chilling. After chilling (approximately 28 h), LMA, BF, HCW, KPH, 
marbling score, skeletal maturity, and lean maturity were collected on the left side of the 
carcass by trained personnel. Carcass and quality data were collected from a dark cutter 
in the Cr300 treatment, but is not represented in quality measurements from the LM, 
WBSF, or cook loss. Strip loins (n = 30, IMPS 180) were tracked through fabrication and 
transported under refrigeration to South Dakota State University meat laboratory for 
further processing. Strip loins were denuded and the first steak was removed for 
proximate analysis. Four steaks (2.54 cm) were cut starting from the anterior end and 
were allotted sequentially for Warner-Bratzler shear force (WBSF) at 7, 14, 21, and 28 d 
postmortem. Steaks were held in refrigeration (1.7 – 4.4°C) until designated aging period 
was reached and then frozen at -20°C until WBSF could be performed. Shear force and 
proximate analysis of LM was performed as previously described.  
Statistical Analysis  
 Carcass data, pH, proximate analysis of LM, and 9-10-11 rib data were analyzed 
as a completely randomized design in PROC MIXED (SAS Inst. Inc., Cary, NC) with 
diet as the main effect. Shear force and western blot data were run as a repeated measure 
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in PROC MIXED using the Toeplitz covariance structure. Diet, age period, and diet x age 
were the main effects for Exp. 1 WBSF. Peak internal temperature was added as a 
covariate for Experiment 2 WBSF and percent cook loss in both experiments. Gene 
expression was analyzed using REST 2009 (Relative Expression Software Tool v2.0, 
Corbett Research and M. Pfaffl, Technical University Munich) by normalizing target 
genes to housekeeping genes. Animal was the experimental unit for all analyses and 
significance was considered at P < 0.05 and trends at P < 0.10. 
RESULTS 
Exp. 1 
 The purpose of Exp. 1 was to evaluate the effects of Cr supplementation on beef 
carcass traits and cellular mechanisms related to the insulin pathway. Therefore, the live 
animal data presented in Table 6 is for characterization of the animals in the experiment, 
not to determine the effects of Cr on performance. Carcass and meat quality data is 
reported in Table 7. There were no differences in final BW or HCW (P > 0.10) between 
treatments. However, Cr400 steers had numerically lighter final body weights and 
numerically heavier carcasses leading to an increase in DP (61.8% vs. 63.3%, CON vs. 
Cr400 respectively; P = 0.03). There was no difference in BF, LMA, YG, or maturity. 
CON steers had a 0.4% decrease in percent KPH compared to Cr400 (P = 0.03). 
Additionally, Cr400 treated steers had decreased marbling scores (P = 0.046) and a trend 
for a decrease in percent IMF (P = 0.07). No difference was observed in pH or color 
scores (P > 0.10) of LM steaks between treatments. The Hankins and Howe (1946) 9-10-
11 rib procedure revealed there were no difference of the estimated carcass composition 
(percent bone, fat, protein, or moisture) or estimated composition of the edible portion 
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(percent fat, protein, and moisture) as denoted in Tables 8 and 9, respectively. Warner 
Bratzler shear force values were increased for steaks from Cr400 compared to CON (P = 
0.02; Table 10). Also, Cr400 steaks had an increase in cook loss vs. CON (P = 0.01). 
Longissimus muscle biopsies observed no difference in relative abundance of Akt, 
phospho-Akt, or p70S6K at biopsy184 (P > 0.10), while growth was promoted with the 
terminal implant, or at biopsy200 when RAC was supplemented (P > 0.10; Table 11).  
However, the protein related to adipogenesis, PPARγ, had a tendency to be higher in 
CON steers vs. Cr400 steers at biopsy184 (P = 0.09), but this trend was diminished by 
biopsy200 (P > 0.10). In conjunction, gene expression of GLUT4 or GLUT1 was 
unchanged at either biopsy time point (P > 0.10) and is depicted in Figure 2.1.  
Exp. 2 
 Experiment 2 was conducted as a follow up study to Exp.1. A subsample of steers 
were chosen at the end of an ongoing feeding trial to determine if differences in carcass 
traits and shear force data would parallel results from Exp. 1. There was no difference in 
final BW, HCW, DP, BF, LMA, YG or maturity between CON and Cr300 (P > 0.10; 
Table 7). There was a trend for percent KPH to be higher for CON than Cr300 (P = 0.10). 
Marbling score and IMF were not different between treatments (P > 0.10). Shear force 
and percent cook loss were not different (P > 0.10; Table 10). However, there was an 
interaction for percent cook loss between treatment and aging period (P = 0.04), which is 
depicted in Figure 2.2.  
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DISCUSSION 
Of the literature with Cr supplemented to feedlot cattle, there is limited 
information on how Cr could influence carcass traits. Original Cr studies with cattle 
focused on steers during the receiving period, and conclude Cr generally alleviates the 
detrimental effects of stress (Moonsie-Shageer and Mowat, 1993; Borgs and Mallard, 
1998). Blood metabolite studies showed Cr improved insulin sensitivity during receiving 
(Sumner et al., 2007; Spears et al., 2012). From this information others have continued Cr 
through finishing to evaluate if the increased insulin sensitivity would translate to 
increased growth. However, there is a wide variation in experimental designs between 
studies. Two of the main differences are the duration of Cr (35d – 222d) and starting BW 
(240 kg – 527 kg). This has caused inconsistency among carcass traits, because when 
significance of a trait or traits is reported it is not repeated in other studies (Chang et al., 
1992; Valdes-Garcia et al., 2011; Song et al., 2013; Sánchez-Mendoza et al., 2014). 
Similarly, the changes in DP, KPH, WBSF, and marbling for Exp.1 were not repeated in 
Exp. 2. Therefore, if Cr is improving insulin sensitivity, it has not consistently increased 
growth of carcass tissues. 
 The lack of repeatability between the two experiments in this research could be 
attributed to the difference in animal model (calf-feds vs. yearlings) when starting Cr 
trials as well as duration of Cr supplementation as indicated above. Yearlings are older in 
age and have heavier body weights when starting in the feedlot compared to calf-feds, 
which means they differ in maturity and are at different points in their growth curve. 
Yearlings are placed on grass for several months during their growing phase and have a 
slower rate of growth (Coleman et al., 1993). This slow rate of growth causes restriction 
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of nutrients to lower priority tissues (i.e. fat depots). Nonetheless, once yearling cattle 
start consuming the high-energy diet, fat will have an exponential rate of growth (Dolezal 
et al., 1993). In contrast, calf feds are placed in the feedlot throughout the growing and 
finishing phases; this allows for unrestricted development of all tissues. Generally this 
results in calf-feds having lighter final BW and HCW because they reach a common 
backfat thickness earlier compared to yearlings (Dolezal et al., 1993). Thus, calf-feds 
were at a different point of development when Cr supplementation began. Also, tissue 
demand for nutrients is different at different stages of growth. Insulin regulates the cell 
metabolism, substrate uptake, and anabolic growth (Saltiel and Kahn, 2001), thus Cr 
could affect insulin sensitive tissues differently between calf-feds and yearlings. 
Furthermore, Cr has shown to increase HCW with longer supplementation (Song et al., 
2013). This could be another explanation why there were more differences in Exp. 1 vs. 2 
since animals were supplemented for 72 d longer in Exp. 1. 
Significant increases in HCW has been observed in Pollard et al. (2002), Barajas 
et al. (2008), and Song et al. (2013). Although not significant, the trend for numeric 
improvements in HCW among the remaining literature is noteworthy (Valdes-Garcia et 
al., 2011; Sánchez-Mendoza et al., 2014; Bibber et al., 2015; Kneeskern et al., 2016), as 
well as in both of our experiments. Bohrer et al. (2014) and Edenburn et al. (2016) are the 
only studies reporting numeric decreases in HCW, but the focus of these studies was 
determining if there was an additive effect of Cr and RAC during the last 30 – 60 days of 
finishing. The authors indicated Cr did not heighten the effects of RAC on carcass traits. 
Overall, the small numbers used in Cr research, including our studies, could have be a 
limitation to determine whether Cr supplementation can increase carcass weights.  
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As stated previously, data between experiments were not consistent, which holds 
true among the literature. Kneeskern et al. (2016) reported Cr increased DP, which agrees 
with the increased DP in Exp. 1. This 1.5% increase in DP in Cr400 steers is partially due 
to of the 0.4% increase in KPH. Yet, the increased KPH does not completely account for 
the increase in DP. This indicates Cr supplementation increased tissue accumulation in 
calf-feds that was not identified by carcass composition measurements, yield grade, or 
carcass data. The effect of Cr400 on KPH in Exp. 1 conflicts with Exp. 2. Instead, KPH 
tended to decrease in Cr300 steers in Exp. 2. The only reported difference in KPH has 
been for a linear decrease in KPH with increasing Cr dosage (Valdes-Garcia et al., 2011) 
agreeing with the latter of our experiments. Therefore, the effect Cr has on KPH is 
inconclusive, but the increase in DP supports the potential for increases in tissue 
accumulation. 
Despite the 0.5 kg increase in shear force from steaks from Cr400 steers, mean 
WBSF values for all treatments in both experiments were below 4.4 kg. This is the 
threshold consumers consider a steak tender (Platter et al., 2003). Moreover, treatments in 
both experiments had mean WBSF values less than 3.9 kg qualifying steaks for the 
marketing claim Certified Very Tender (International, 2011). It should also be noted 
aging period was significant to WBSF, in both experiments, demonstrating steaks were 
normal as tenderness increased during the aging period. Previous literature has not 
reported a change in WBSF from beef steaks (Bohrer et al., 2014; Edenburn et al., 2016), 
lamb chops (Arvizu et al., 2011), or pork chops (Sales and Jancik, 2011) from animals 
supplemented Cr or not supplemented. Therefore, the difference in Exp. 1 indicates Cr 
supplementation with calf-fed steers throughout growing and finishing may decrease 
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tenderness, but supplementing Cr to yearling steers resulted in no difference in 
tenderness.   
As previously mentioned, peak internal temperature was used as a covariant for 
cook loss in Exp. 1 and 2, because peak internal temperature contributes significantly to 
cook loss (Brewer and Novakofski, 1999). Previous literature has reported no difference 
in cook loss of beef steaks from steers supplemented Cr (Edenburn et al., 2016). There 
were indications of increased water holding capacity when pigs were supplemented Cr as 
cooler shrink was decreased for carcasses (Lindemann et al., 2008), and thaw loss 
(Matthews et al., 2003), purge loss (Matthews et al., 2006), and cook loss (Shelton et al., 
2003) were decreased in loin chops. However, a meta-analysis of pigs supplemented Cr 
did not observe these traits to be different (Sales and Jancik, 2011). Thus, variation in 
degree of doneness of steaks could been the reason for increased cook loss with Cr400 in 
Exp. 1 and the interaction of treatment and aging period in Exp. 2.  
  Most Cr studies have not included the use of an implant strategy coupled with 
RAC during supplementation, which are two common technologies utilized within US 
feedlots to enhance efficiency of gain and pounds of red meat produced per animal. The 
two LM biopsies were collected to evaluate how Cr could be influencing growth when 
current technologies are applied, and how mechanisms downstream of insulin are 
involved. A mechanism through which implants are proposed  to increase lean growth is 
by increasing circulating insulin-like growth factor (IGF) concentrations as well as 
increasing IGF production within skeletal muscle (Hossner, 2005). Insulin-like growth 
factor can mediate its effect through the same pathway as insulin, and the result is an 
increase in muscle hypertrophy (Delavaud et al., 2002; Du and McCormick, 2009). 
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Ractopamine hydrochloride, a beta-agonist, is considered a “repartitioning agent”. 
Ractopamine hydrochloride is fed for the last 28-42 d of finishing, when animals have 
reduced lean growth and rapid fat development (Johnson et al., 2014a). Feeding RAC 
dramatically increases demand for nutrients by skeletal muscle at the expense of adipose 
(Mersmann, 1998). This shift causes an increase in protein synthesis and lipolysis and a 
decrease in lipogenesis (Mersmann, 1998; Johnson et al., 2014a). The use of these 
technologies cause dramatic changes to the animal’s physiology; thus, Cr effects on 
insulin signaling could be diminished by these potent technologies.  
Proteins downstream of insulin were measured at each biopsy to determine if 
there is a difference in insulin signaling with the use of implants or RAC. It is well 
understood phosphorylation of Akt is a necessary for continuing intracellular signaling of 
insulin (Alessi et al., 1996), and Cr supplementation has shown to increase 
phosphorylation of Akt at Serine 473 (Chen et al., 2009b), which is a site required for 
complete activation of Akt (Alessi et al., 1996). Activation of Akt leads to translocation 
of GLUT4 to the cell membrane for glucose absorption (Shepherd and Kahn, 1999), and 
causes increased activity of p70S6K, which is responsible for regulating protein synthesis 
(Inoki et al., 2002). Lastly, GLUT4 and 1 gene expression were measured, because 
insulin signaling leads to increased GLUT4 gene transcription (Gomperts et al., 2004). In 
addition, GLUT1 is responsible for basal glucose uptake and is higher in ruminants 
verses other species (Duhlmeier et al., 2005). Representative western blots for relative 
protein abundance determination are depicted in Figures 2.3, 2.4, and 2.5. Since there 
was no difference observed with the proteins and genes measured indicates Cr did not 
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have an additive effect on proteins related to insulin signaling or genes related to glucose 
transporters when steers were given growth promoters.  
 Tokach et al. (2015) evaluated gene expression coupled with protein abundance in 
cell cultures of bovine satellite cells (muscle). Supplementation increased myotube 
number and diameter in satellite cells compared to control. Also, Cr led to no changes in 
GLUT4 mRNA expression, which agrees with our data. But there was a decrease in the 
ratio of protein abundance between GLUT4 and GAPDH (glyceraldehyde 3-phosphate 
dehydrogenase) with Cr supplementation (Tokach et al., 2015). The authors stated the 
decrease in GLUT4:GAPDH combined with the changes in myotube number and 
diameter indicates the muscle cells are more efficient at glucose absorption, because there 
was increased growth with less glucose receptors present at the cell membrane. Also, a 
technical report by Kemin Industries (2016) observed Cr increased internalization of 
GLUT4 (P = 0.01)  from LM biopsies in conjunction with a numeric increase in HCW. 
They concluded the increased internalization of GLUT4 leads to less GLUT4 at the cell 
membrane to absorb glucose. The researchers made the similar conclusion as Tokach et 
al. (2015) that Cr increases gain through more efficient absorption of glucose. This theory 
could explain why Cr400 increased DP with no difference in proteins related to the 
insulin pathway in Exp.1. This data provides the basis that Cr could be potentiating basal 
glucose uptake independent of insulin signaling and translocation of GLUT4.  
Adipogenesis, the development of fat, is regulated by PPARγ (Tontonoz and 
Spiegelman, 2008). Cell culture work showed Cr increased PPARγ expression in bovine 
intramuscular adipocytes (Tokach et al., 2015). This work indicated Cr supplementation 
could increase IMF and subsequently garner premiums for increased beef quality grades. 
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However, only numeric increase in marbling scores have only been reported in Exp. 2 
and in Sánchez-Mendoza et al. (2014). Marbling scores have been significantly decreased 
with Cr400 in Exp. 1. As well, 400 ppm Cr decreased marbling score compared to CON 
or 200 ppb Cr in Pollard et al. (2002) and tended to decrease in (Kneeskern et al., 2016). 
Noteworthy, is the 16.4% increase of USDA Select steers reported in Edenburn et al. 
(2016) in steers supplemented Cr. Furthermore, the first muscle biopsy indicated a trend 
for decreased PPARγ in the LM of Cr400 steers. Since marbling development occurs 
during the growing phase and PPARγ regulates adipogenesis, the timing of the biopsy 
may not have been optimal to measure Cr effects on PPARγ in vivo. Moreover, it is 
presumed IMF and connective tissue may be in competition for the limited pool of 
progenitor cells during development (Du et al., 2013). If connective tissue development is 
activated, then progenitor cells would be destined for this cell line, and this could leave a 
smaller pool of progenitor cells for IMF development (Du et al., 2013). This could 
explain the decrease in marbling along with the increase in toughness observed in Exp. 1. 
However, it is unknown what caused the increased WBSF values, because the amount of 
connective tissue or other traits known to affect tenderness were not measured in these 
studies. Nonetheless, supplementing Cr could potentially cause an increase in connective 
tissue at the expense of intramuscular adipogenesis.  
 Researchers have established carcass tissues have a different response to Cr. 
Intramuscular adipocytes increased GLUT4 mRNA, GLUT4 abundance, and PPARγ 
mRNA with Cr (Tokach et al., 2015). Subcutaneous (SC) adipocytes did not differ in 
PPARγ or GLUT4 expression or GLUT4 abundance. The authors concluded IMF is more 
sensitive to Cr than SC fat. In the live animal, IMF is not in competition with SC fat for 
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glucose, because SC fat utilizes more acetate than glucose as carbon sources (Smith and 
Crouse, 1984), but IMF is competing for glucose with muscle. Insulin stimulation of 
muscle causes a 7-10 times higher absorption of glucose into muscle versus fat (Shulman 
et al., 1990; Perseghin et al., 1996), so muscle has a higher affinity for glucose over fat 
when stimulated by insulin. Therefore, Cr supplementation could be increasing muscle 
glucose absorption at the expense of IMF, which could explain the increased DP and 
decreases in marbling observed in this data and previous fed cattle research.  
 
CONCLUSION 
The hypothesis of our research was Cr would increase accretion of economically 
important carcass traits: HCW, DP, and marbling. However, this was not proven within 
our research. Even though DP was increased for Exp. 1, it was not replicated in Exp. 2. In 
the live animal, marbling is likely reduced with Cr since marbling and skeletal muscle are 
in competition for glucose. Overall, the increased DP and decreased marbling in Exp. 1 
could be a residual effect of Cr increasing muscle growth at the expense of fat during the 
growing phase. An additive effect with Cr was not observed with the utilization of 
terminal implants or RAC as measured by proteins related to anabolic muscle growth. 
Therefore, any affects of Cr could potentially be negated by these potent technologies. 
Nonetheless, Cr research should continue in cattle designated towards alternative 
marketing programs that do not allow the use of implants or beta-agonists. There is the 
potential for Cr to be a natural growth-promoting supplement allowing for beef producers 
to more efficiently produce beef under these marketing programs.  
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 d 4 - 183 d 184 - 210 
S1480 Supplement CONb Cr400b CONb Cr400b 
Wheat Middlings, kg 453.5 453.5 – 453.5 
Ground Corn, kg  453.5 449.4 – 449.4 
Chromium Propionate,c kg – 4.1 – 4.1 
     
Optaflexx supplement     
Corn, kg – – 612 612 
Wheat middlings, kg – – 272 272 
Binder, kg  – – 7.3 7.3 
Premix      
- Optaflexx 45,d kg – – 7.56 7.56 
- Corn, kg – – 7.84 7.84 
a As Is basis  
b CON = 0 ppb chromium propionate; Cr400 = 400 ppb chromium propionate 
c KemTRACE 0.4% Chromium Propionate 
d 99 g of ractopamine hydrochloride per kg of Optaflexx 45  
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Pelleted supplement formulations to include chromium and 
ractopamine hydrochloride in cattle diets for Exp. 1a 
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 d 89 - 146  d 147 - 183  d 184 - 210 
 
All 
treatments  CONb Cr400b  CONb Cr400b 
Corn silage, %  –  11 11  11 11 
HMC,c % 83.9  35 35  35 35 
DDGS,c % 9.6  – –  – – 
DRC,c % –  34.75 32.75  32.75 30.75 
mDGS,c % –  15 15  15 15 
S1480,d % 2.0  – 2.0  – 2.0 
Liquid Supplement,e % 4.5  4.25 4.25  4.25 4.25 
Optaflexx Supplement,f % –  – –  2.0 2.0 
        
CP,c % 13  13 13  13 13 
NEG,c Mcal/kg 1.34  1.41 1.41  1.41 1.41 
a on a dry matter basis 
b CON = 0 ppb chromium propionate; Cr400 = 400 ppb chromium propionate 
c High moisture corn (HMC), Dried Distillers Grains with Solubles (DDGS), Dry 
Rolled Corn (DRC), Modified Distillers Grains with Solubles (mDGS), Crude 
Protein (CP), Net Energy for gain (NEg) 
d pelleted carrier for chromium propionate  
e supplement contained vitamins and minerals to meet or exceed NRC requirements  
f pelleted carrier for ractopamine hydrochloride 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Percent of feedstuffs of the finishing diets and calculated crude 
protein and net energy of gain for Exp. 1a 
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Gene  Primer Sequence Accession Number 
EEF1A2*a forward 5’ – GGTACTGGACAAGCTGAAGG – 3’  NM_001037464 
 reverse 5’ – GCGTCGATGATGGTGATGTA – 3’  
SF3A1*b forward 5’ – GCCCGTGGTGGGTATTATTTA – 3’ NM_001081510 
 reverse 5’ – TGTTGATCTCGTTCTGTCGTATC – 3’  
GLUT 1c forward 5’ – GATGATGCGGGAGAAGAAGG NM_174602.2 
 reverse 5’ – TGAAGGCTGTGTTGACGATG  
GLUT 4d forward 5’ – AGTGGCTGGGAAGGAAGAGG NM_174604.1 
 reverse 5’ – TAGCACCTGGGCGATTAGGA   
* Housekeeping Gene 
a Eukaryotic Translation Elongation Factor 1, alpha 2; b Splicing Factor 3, subunit 1 
c Glucose Transporter 1, bovine; d Glucose Transporter 4, bovine 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.  Primer sequences for house-keeping and genes of interest for longissimus 
muscle biopsy  
 
 
44 
 d 1 – 105  d 106 - 138 
S1580 Supplement CONb Cr300b  CONb Cr300b 
Soy hulls, kg  320 315  386 381 
Soybean meal, kg 587 588  735 735 
Chromium Propionate,c kg – 4.06  – 5.08 
Optaflexx 45,d kg – –  13.70 13.70 
a As Is basis  
b CON = 0 ppb chromium propionate; Cr300 = 300 ppb chromium propionate  
c KemTRACE 0.4% Chromium Propionate 
d 99 g of ractopamine hydrochloride per kg of Optaflexx 45  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4. Pelleted supplement formulations to include chromium and 
ractopamine hydrochloride in cattle diets for Exp. 2a 
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  d 8 - 120 d 121 - 138 
Corn silage, %  12.25 – 
Grass Hay, % – 8.15 
HMC,b % 34.02 35.19 
DRC,b % 32.18 33.56 
mDGS,b % 14.83 16.38 
S1580,c % 1.95 1.99 
Liquid Supplement,d % 4.78 4.75 
   
CP,b % 13 13 
NEG,b Mcal/kg 1.41 1.43 
a on a dry matter basis 
b High moisture corn (HMC), Dry Rolled Corn (DRC), Modified Distillers 
Grains with Solubles (mDGS), Crude Protein (CP), Net Energy for gain 
(NEg) 
c pelleted carrier for chromium propionate and ractopamine hydrochloride 
d supplement contained vitamins and minerals to meet or exceed NRC 
requirements  
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5. Percent of feedstuffs of the finishing diets and calculated 
crude protein and net energy of gain for Exp. 2a 
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 Exp. 1a  Exp. 2a 
 CONb Cr400b SEM P-value  CONb  Cr300b SEM  P-value 
 n = 2 n = 2    n = 16 n = 16   
Initial BW, kg 288 287 4 0.88  406 412 7 0.60 
Final BW, kg 660 655 6 0.63  674 691 15 0.44 
ADG,c kg 1.81 1.79 0.07 0.81  1.94 2.02 0.07 0.44 
Total days of Cr 
supplementation  0 d 210 d    0 d 130 d   
a Exp. 1 = 150 days on finishing diet; Exp. 2 = 138 days on finishing diet  
b CON = 0 ppb chromium propionate; Cr400 = 400 ppb chromium propionate; Cr300 = 300 
ppb chromium propionate 
c ADG calculated over the finishing phase  
Table 6. Live animal performance data from steers supplemented chromium 
propionate for both Exp. 1 and Exp. 2 
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Table 7. Carcass data and quality data of longissimus muscle from steers supplemented chromium propionate for both Exp. 1 
and Exp. 2a 
 
Exp. 1  Exp. 2 
 
CONb SEM Cr400b SEM P-value  CONb SEM Cr300b SEM P-value 
n = 12  n = 14    n = 16  n = 16   
HCW, kg 396 6 402 6 0.46  407 10 419 10 0.42 
Dressing Percent,c % 61.77 0.47 63.26 0.43 0.03  62.23 0.50 62.52 0.50 0.68 
12th Rib Backfat, cm 1.24 0.13 1.37 0.12 0.44  1.09 0.10 1.33 0.10 0.11 
LMA,d cm2 90.3 1.9 91.5 1.7 0.65  92.6 2.1 96.5 2.1 0.20 
KPH, % 1.79 0.12 2.18 0.11 0.02  1.94 0.09 1.72 0.09 0.10 
Yield Gradee 2.89 0.19 3.11 0.17 0.39  2.77 0.17 2.88 0.17 0.63 
Lean Maturityf 153 18 130 17 0.37  144 13 165 13 0.26 
Skeletal Maturityf 105 3 106 3 0.87  143 5 153 5 0.15 
            
 n = 11  n = 14    n = 15  n = 14   
Marbling Scoreg 512 19 459 17 0.046  432 16 449 16 0.45 
IMF,h % 6.20 0.45 5.09 0.40 0.07  5.02 0.36 5.18 0.35 0.76 
IMM,h % 71.23 0.35 71.94 0.31 0.12  71.93 0.28 71.85 0.27 0.83 
pH 5.54 0.03 5.51  0.03 0.46  – – – – – 
L* 43.68 0.54 43.26 0.48 0.57  – – – – – 
a* 26.41 0.32 27.03 0.29 0.17  – – – – – 
b* 11.86 0.20 12.21 0.18 0.22  – – – – – 
a Least square means 
b CON = 0 ppb supplemental chromium propionate; Cr400 = 400 ppb chromium propionate; Cr300 = 300 ppb chromium propionate 
c HCW / Final body weight with 3% percent shrink 
d Longissimus muscle area 
e calculated based on equations from USDA (2016) 
f A = 100, B = 200 
g Marbling Score: Small = 400, Modest = 500 
h Intramuscular fat (IMF), Intramuscular moisture (IMM) 
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Table 8. Estimated carcass composition using the 9-10-11 rib 
procedure for steers from Exp. 1ab 
 CONc SEM Cr400c SEM P-value 
 n = 5  n = 6   
Bone 13.65% 0.29 13.42% 0.27 0.56 
Protein  13.32% 0.24 13.46% 0.22 0.67 
Fat 27.10% 1.43 25.93% 1.30 0.56 
Moisture  45.66% 0.91 46.71% 0.83 0.42 
a Least Square Means 
b 9-10-11 rib procedure Hankins and Howe, 1946  
c CON = 0 ppb chromium propionate, Cr400 = 400 ppb chromium 
propionate  
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Table 9. Estimated composition of edible portion using the 9-10-
11 rib procedure for steers from Exp. 1ab 
 CONc SEM Cr400c SEM P-value 
 n = 5  n = 6   
Protein  15.43% 0.31 15.55% 0.28 0.78 
Fat 31.36% 1.55 29.95% 1.42 0.52 
Moisture  52.89% 1.19 53.96% 1.08 0.52 
a Least Square Means 
b 9-10-11 rib procedure Hankins and Howe, 1946  
c CON = 0 ppb chromium propionate, Cr400 = 400 ppb chromium 
propionate  
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Table 10. Warner-Bratzler shear force and cook loss of Longissimus steaks from steers supplemented chromium propionate for 
both Exp. 1 and Exp. 2a 
 Treatment  Age   P-value 
Exp. 1 CONb SEM Cr400b SEM  6 d 14 d 21 d   SEM  Trt Age Trt x Age 
 n = 11  n = 14   n = 25 n = 25 n = 25       
WBSF,c kg 2.56 0.12 2.95 0.11  3.17x 2.78xy 2.32y – 0.20  0.02 0.0003 0.98 
Cookloss,d* % 19.88 0.29 20.90 0.26  22.02x 20.93y 18.22z – 0.47  0.01 < 0.0001 0.13 
               
Exp. 2  CONb SEM Cr300b SEM  7 d 14 d 21 d  28 d SEM  Trt Age Trt x Age 
 n = 15  n = 15   n = 30 n = 30 n = 30 n = 30      
WBSF,* kg 2.70 0.07 2.83 0.07  3.12x 2.86x 2.58y 2.49y 0.10  0.20 < 0.0001 0.40 
Cookloss,* % 19.85 0.33 19.27 0.33  20.13 19.53 19.01 19.59 0.81  0.23 0.41 0.04 
               
a Least Square Means 
b CON = 0 ppb chromium propionate; Cr400 = 400 ppb chromium propionate; Cr300 = 300 ppb chromium propionate 
c Warner-Bratzler shear force 
d Cookloss = ((fresh weight – cooked weight) / fresh weight)*100 
xyz means with different superscripts differ (P ≤ 0.05) 
* peak eternal temperature used as a covariant 
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Table 11. Western blot relative protein abundance within Longissimus muscle 
biopsies between steers supplemented chromium and between biopsies for Exp. 
1ab 
 CONb SEM Cr400c SEM P-value 
Biopsy184d n = 9  n = 10   
PPARγe 0.68 0.13 0.37 0.12 0.09 
AKTf 0.027 0.004 0.036 0.004 0.22 
AKT(Ser473)g 1.25 0.18 1.21 0.17 0.87 
p70-S6Kh 0.046 0.004 0.056 0.004 0.11 
      
Biopsy200i n = 10  n = 10   
PPARγ 0.32 0.12 0.30 0.12 0.92 
AKT 0.042 0.004 0.043 0.004 0.96 
AKT(Ser473) 1.25 0.16 0.99 0.17 0.27 
p70-S6K 0.054 0.004 0.053 0.004 0.90 
      
 Biopsy184 SEM Biopsy200 SEM P-value 
 n = 19  n = 20    
PPARγ 0.52 0.09 0.31 0.09 0.095 
AKT 0.031 0.003 0.043 0.003 0.03 
AKT(Ser473) 1.22 0.12 1.12 0.12 0.53 
p70-S6K 0.056 0.003 0.053 0.003 0.56 
a Least Square Means 
b Target protein intensity was normalized to Actin intensity then standardized to a 
reference sample  
c CON = 0 ppb chromium propionate, Cr400 = 400 ppb chromium propionate 
d Longissimus muscle biopsy taken after adaptation to terminal implant  
e Peroxisome proliferator-activated receptor gamma 
f Protein kinase B  
g Protein kinase B phosphorylated at serine 473  
h Ribosomal protein S6 kinase 1 
i Longissimus muscle biopsy taken after adaptation to ractopamine 
 hydrochloride 
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 Biopsy 1  Biopsy 2 
 GLUT 4 GLUT 1  GLUT 4 GLUT 1 
CON  1 1  1 1 
Cr400 2.633 1.221  1.463 1.273 
P-value 0.152 0.601  0.285 0.334 
Figure 2.1. Influence of chromium on gene expression of glucose transporter 4 and 1 in 
longissimus muscle from steers supplemented either 0 ppb (CON) or 400 ppb chromium 
propionate (Cr400) in Exp. 1. Biopsy 1 was taken after adaption to terminal implant (n=9 
CON; n=10 Cr400), and biopsy 2 was taken after adaption to ractopamine hydrochloride 
(n=10 per treatment). Relative expression is reported on a base gene expression level of 1 
for the CON treatment. No differences were observed in relative expression of genes 
between treatments (P > 0.05). 
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Figure 2.2. Percent cook loss interaction between treatment and aging period of 
longissimus steaks from steers supplemented either 0 ppb (CON) or 300 ppb chromium 
propionate (Cr300) aged for 7, 14, 21, and 28 d in Exp. 2. Main effects of treatment and 
aging period were not significant (P > 0.05). Peak internal temperature contributed variation to 
cook loss (P < 0.001) and used a covariant. Error bars reflect the standard error of the mean and n 
= 16 steaks for each treatment at each aging period. 
0	
5	
10	
15	
20	
25	
7	d	 14	d	 21	d	 28	d	
Co
ok
lo
ss
,	%
	
Aging	Period		
Ctrl	
Cr300	
*	P	=	0.01	
	
 
 
54 
 
 
Figure 2.3. Representative western blot of peroxisome proliferator-activated receptor γ 
(PPARγ) from bovine longissimus muscle biopsies from steers supplemented either 0 ppb 
(CON) or 400 ppb chromium propionate (Cr400) in Exp. 1. Blot prepared from 15% Tris-
HCl gels transferred to a polyvinylidene difluoride membrane and labeled with anti-
PPARγ antibody (Santa Cruz Biotechnology, sc-1984).  
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a) Akt 
 
b) phospho-Akt(ser473)  
  
Figure 2.4. Representative western blot of a) protein kinase B (Akt)  and b) Akt 
phosphorylated at Serine 473 from bovine longissimus muscle biopsies from steers 
supplemented either 0 ppb (CON) or 400 ppb chromium propionate (Cr400) in Exp. 1. 
Blots prepared from 4 – 20% Tris-HCl gels transferred to nitrocellulose membranes and 
labeled with anti-Akt and anti-phospho Akt(Ser473; Santa Cruz Biotechnology, sc-8312 
and sc-7985, respectively).  
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Figure 2.5. Representative western blot of ribosomal protein S6 kinase 1 (p70S6K) from 
bovine longissimus muscle biopsies from steers supplemented either 0 ppb (CON) or 400 
ppb chromium propionate (Cr400) in Exp. 1. Blots prepared from 4 – 20% Tris-HCl gels 
transferred to nitrocellulose membranes and labeled with anti-p70S6K rabbit (Cell 
Signaling Technology, 9202).
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